SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-051416
Filing Date
2024-06-10
Accepted
2024-06-10 18:30:25
Documents
2
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3828
2 POWER OF ATTORNEY ea020759608ex24_jasper.htm EX-24 6132
  Complete submission text file 0001213900-24-051416.txt   11524
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O QIMING U.S. HEALTHCARE 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address
French Anna Louise (Reporting) CIK: 0001871871 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39138 | Film No.: 241034111